These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 9042913)

  • 21. Compound heterozygosity for a disease-causing G1489E [corrected] and disease-modifying G530S substitution in COL5A1 of a patient with the classical type of Ehlers-Danlos syndrome: an explanation of intrafamilial variability?
    Giunta C; Steinmann B
    Am J Med Genet; 2000 Jan; 90(1):72-9. PubMed ID: 10602121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delineation of Ehlers-Danlos syndrome phenotype due to the c.934C>T, p.(Arg312Cys) mutation in COL1A1: Report on a three-generation family without cardiovascular events, and literature review.
    Colombi M; Dordoni C; Venturini M; Zanca A; Calzavara-Pinton P; Ritelli M
    Am J Med Genet A; 2017 Feb; 173(2):524-530. PubMed ID: 28102596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single base mutation in COL5A2 causes Ehlers-Danlos syndrome type II.
    Richards AJ; Martin S; Nicholls AC; Harrison JB; Pope FM; Burrows NP
    J Med Genet; 1998 Oct; 35(10):846-8. PubMed ID: 9783710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compound phenotype of osteogenesis imperfecta and Ehlers-Danlos syndrome caused by combined mutations in
    Lin Z; Zeng J; Wang X
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31239369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial Ehlers-Danlos syndrome with lethal arterial events caused by a mutation in COL5A1.
    Monroe GR; Harakalova M; van der Crabben SN; Majoor-Krakauer D; Bertoli-Avella AM; Moll FL; Oranen BI; Dooijes D; Vink A; Knoers NV; Maugeri A; Pals G; Nijman IJ; van Haaften G; Baas AF
    Am J Med Genet A; 2015 Jun; 167(6):1196-203. PubMed ID: 25845371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecular basis of classic Ehlers-Danlos syndrome: a comprehensive study of biochemical and molecular findings in 48 unrelated patients.
    Malfait F; Coucke P; Symoens S; Loeys B; Nuytinck L; De Paepe A
    Hum Mutat; 2005 Jan; 25(1):28-37. PubMed ID: 15580559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I.
    Takahara K; Schwarze U; Imamura Y; Hoffman GG; Toriello H; Smith LT; Byers PH; Greenspan DS
    Am J Hum Genet; 2002 Sep; 71(3):451-65. PubMed ID: 12145749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood.
    Malfait F; Symoens S; De Backer J; Hermanns-Lê T; Sakalihasan N; Lapière CM; Coucke P; De Paepe A
    Hum Mutat; 2007 Apr; 28(4):387-95. PubMed ID: 17211858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular aspects of the Ehlers-Danlos Syndromes.
    Malfait F
    Matrix Biol; 2018 Oct; 71-72():380-395. PubMed ID: 29709596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II).
    Schwarze U; Atkinson M; Hoffman GG; Greenspan DS; Byers PH
    Am J Hum Genet; 2000 Jun; 66(6):1757-65. PubMed ID: 10796876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations of the alpha2(V) chain of type V collagen impair matrix assembly and produce ehlers-danlos syndrome type I.
    Michalickova K; Susic M; Willing MC; Wenstrup RJ; Cole WG
    Hum Mol Genet; 1998 Feb; 7(2):249-55. PubMed ID: 9425231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Classic Ehlers-Dalnos syndrome presenting as atypical chronic haematoma: a case report with novel frameshift mutation in COL5A1.
    Chiu WC; Chen SH; Lo MC; Kuo YT
    BMC Pediatr; 2020 Oct; 20(1):495. PubMed ID: 33109150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Murine model of the Ehlers-Danlos syndrome. col5a1 haploinsufficiency disrupts collagen fibril assembly at multiple stages.
    Wenstrup RJ; Florer JB; Davidson JM; Phillips CL; Pfeiffer BJ; Menezes DW; Chervoneva I; Birk DE
    J Biol Chem; 2006 May; 281(18):12888-95. PubMed ID: 16492673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen.
    Byers PH; Duvic M; Atkinson M; Robinow M; Smith LT; Krane SM; Greally MT; Ludman M; Matalon R; Pauker S; Quanbeck D; Schwarze U
    Am J Med Genet; 1997 Oct; 72(1):94-105. PubMed ID: 9295084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural abnormalities of the cornea and lid resulting from collagen V mutations.
    Segev F; Héon E; Cole WG; Wenstrup RJ; Young F; Slomovic AR; Rootman DS; Whitaker-Menezes D; Chervoneva I; Birk DE
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):565-73. PubMed ID: 16431952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A patient with a novel pathogenic variant in COL5A1 exhibiting prominent vascular and cardiac features.
    Lavanya K; Mahtani K; Abbott J; Jain A; Selvam P; Atwal H; Farres H; Atwal PS
    Am J Med Genet A; 2022 Jul; 188(7):2192-2197. PubMed ID: 35396906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arterial rupture in classic Ehlers-Danlos syndrome with COL5A1 mutation.
    Borck G; Beighton P; Wilhelm C; Kohlhase J; Kubisch C
    Am J Med Genet A; 2010 Aug; 152A(8):2090-3. PubMed ID: 20635400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helical mutations in type I collagen that affect the processing of the amino-propeptide result in an Osteogenesis Imperfecta/Ehlers-Danlos Syndrome overlap syndrome.
    Malfait F; Symoens S; Goemans N; Gyftodimou Y; Holmberg E; López-González V; Mortier G; Nampoothiri S; Petersen MB; De Paepe A
    Orphanet J Rare Dis; 2013 May; 8():78. PubMed ID: 23692737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A family with Ehlers-Danlos syndrome type III/articular hypermobility syndrome has a glycine 637 to serine substitution in type III collagen.
    Narcisi P; Richards AJ; Ferguson SD; Pope FM
    Hum Mol Genet; 1994 Sep; 3(9):1617-20. PubMed ID: 7833919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ehlers-Danlos syndromes. Clinical, genetic and molecular aspects].
    Germain D
    Ann Dermatol Venereol; 1995; 122(4):187-204. PubMed ID: 8526413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.